Oncology horizon scanning project

Abstract

A very strong pipeline of oncology precision medicines will become accessible to patients now and in the immediate future. Over the next five years a range of innovative precision medicines or targeted therapies will reach the market, followed by new immunotherapies. Also, taking as a basis this raising targeted therapeutics pipeline we showed an equivalently raising diagnostics pipeline, not only used for properly targeting precision medicines, but also more and more for screening, monitoring and treatment optimization. In this study we investigate whether Belgium is ready to make this disruptive medical technology available to its citizens.